期刊文献+

糖尿病性勃起功能障碍大鼠模型的建立 被引量:8

Establishment of a rat model of diabetic erectile dysfunction
下载PDF
导出
摘要 目的探讨利用链脲佐菌素(STZ)建立理想糖尿病性勃起功能障碍大鼠模型。方法30只SD大鼠,随机分为5组,分别为对照组、注射STZ40mg/kg组、60mg/kg组、80mg/kg组、100mg/kg组,每组6只,分别记录4d、1周、2周、3周的空腹血糖、阿朴吗啡诱导阴茎的勃起次数及体质量。结果4个时间点间的空腹血糖有显著性差异(P=0.001),不同STZ注射组别间的空腹血糖、勃起次数及体质量改变存在显著性差异(P<0.001,P=0.045及P<0.001),阿朴吗啡阴茎勃起实验的勃起次数及体质量的改变在4个时间点间不存在显著性差异(P=0.306和P=0.628)。结论最佳成糖尿病模型的STZ注射剂量应为60mg/kg,筛选糖尿病性勃起功能障碍模型的阿朴吗啡勃起实验筛选时间应定在注射STZ后的2周左右。 Objeetive To establish a rat model of diabetic erectile dysfunction (ED) with streptozotocin (STZ) injection. Methods Thirty male rats were randomized equally into 5 groups (control group and STZ 40 mg/kg, 60 mg/kg, 80 mg/kg, and 100 mg/kg groups). All the rats were examinaed at 4 days and 1, 2, and 3 weeks after STZ injection for fasting blood glucose, erectile frequency induced by apomorpHine (APO) and body weight changes. Results Significant difference occurred in the fasting food glucose among the groups at different time points (P=0.001), and also in APO-induced erectile frequency, fasting blood glucose and body weight between the groups with STZ injection at different doses (P〈0.001, P=0.045 and P〈0.001, respectively). No significant difference was found in induced erectile frequency and body weight between different time points (P=0.306 and P=0.628). Conclusion The optimal dose of STZ for establishing diabetic ED model is 60 mg/kg, and two weeks after the injection can be the optimal time for evaluating model establishment by means of APO-induced penis erection.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第4期564-566,共3页 Journal of Southern Medical University
基金 全军十五科技计划基金(03M105) 广东省自然科学基金(5B1040144)
关键词 糖尿病 勃起功能障碍 大鼠 链脲佐菌素 diabetes mellitus erectile dysfunction streptozotocin
  • 相关文献

参考文献8

二级参考文献16

  • 1于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 2Ueda H, Ikegami H, Yamato E, et al. The NSY Mouse: a new animal model of spontaneous NIDDM with moderate obesity[J].Diabetologia , 1995,38 : 503 被引量:1
  • 3Rackietan N, Rackietan M L, Nadkarni M R. Studies on diabetogenic action of streptozocin (NSC-37917) [J ]. Cancer Chemother Rep, 1993,29:91 被引量:1
  • 4Pettepher C C, Ledoux S P, Bohr V A, et al. Repair of Alkalilabile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin[J]. J Bio Chem,1991,266:3113 被引量:1
  • 5Lupi R, Dotta F, Marscella L, et al. Prolonged exposure to free fatty acids has cytosatatic and pro-apototic effects on human pancreastic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway and Bcl-2redulated[J]. Diabetes, 2002,51 : 1437 被引量:1
  • 6Mauricio D, Mandrup-Palsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death[J]. Diabetes, 1998,47:1537 被引量:1
  • 7Liuk, Parterson A J, Chin E, et al. Glucose stimulates protein modification by o-linked GlcNAC pancreastic beta cell: Linkage of o-linked GlcNAC to bete cell death [J]. PNAS, 2000,97(6):2820 被引量:1
  • 8Amos A F, Mc Carty D J, Zim Met P [J]. The rising global burden of diabetes and its complications :estimates and projections to the year 2010[J]. Diabet Med, 1997,14(Suppl 5) :SI 被引量:1
  • 9Luo J,Metabolism,1998年,47卷,663页 被引量:1
  • 10Storlien L H,Ann NY Acad Sci,1993年,683卷,57页 被引量:1

共引文献373

同被引文献85

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部